Skip to main content

Breast Cancer - Male News

FDA Approves Piqray (alpelisib) as First PI3K Inhibitor for Breast Cancer

May 24, 2019 -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat ...

FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer

April 4, 2019 – Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to expand the indications for Ibrance...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Breast Cancer

Related drug support groups

tamoxifen